Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

COPD and tobacco smoke.

M Bartal1

  • 1Moroccan Society of Allergology and Clinical Immunology, Casablanca, Morocco. bartalmoh@menara.ma

Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|February 4, 2006
PubMed
Summary

Smoking causes chronic obstructive pulmonary disease (COPD) through inflammation and lung damage. Quitting smoking is the most effective way to reduce COPD risk factors and improve lung function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of wheat ash on the MCPA immobilization in agricultural soils.

Bulletin of environmental contamination and toxicology·2008
Same author

Influence of wheat ash on the MCPA immobilization in agricultural soils.

Bulletin of environmental contamination and toxicology·2007
Same author

[Smoking in Casablanca hospitals: knowledge, attitudes and practices].

Revue des maladies respiratoires·2002
Same author

Health effects of tobacco use and exposure.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2002
Same author

[Skin sensitization to pollens in Morocco. Multicenter study].

Revue des maladies respiratoires·2002
Same author

[Smoking knowledge, attitudes, and behaviors of patients in Morocco].

Revue des maladies respiratoires·2000

Area of Science:

  • Pulmonology
  • Environmental Health

Background:

  • Chronic obstructive pulmonary disease (COPD) is a growing global health concern characterized by airway inflammation.
  • Active and passive smoking, even in utero, are primary risk factors, with individual susceptibility influencing disease development.

Purpose of the Study:

  • To elucidate the mechanisms underlying COPD development and progression.
  • To highlight the impact of smoking cessation on COPD management and patient outcomes.

Main Methods:

  • Review of existing literature on COPD pathogenesis.
  • Analysis of the effects of tobacco smoke on respiratory system components.

Main Results:

  • Tobacco smoke triggers persistent inflammation, protease-antiprotease imbalance, oxidant-antioxidant imbalance, and impaired repair mechanisms.
  • These processes lead to mucus hypersecretion, alveolar destruction, and pulmonary fibrosis, with earlier smoke exposure correlating with greater lung function decline.
  • COPD patients harbor pathogens, increasing infection risk and exacerbations, which further worsen lung function.

Conclusions:

  • Smoking cessation is the single most effective and cost-effective strategy to mitigate COPD risk factors.
  • Quitting smoking reduces hospitalizations, slows lung function decline, improves quality of life, and enhances FEV1, especially when initiated earlier.

Related Experiment Videos